85 Attendance characteristics of the breast and colorectal CSPs Table 2. Results univariate regression analyses on attendance, concerning invitees and breast cancer cases. OR (95% CI) p-value n SES (invitees) SES 1 reference <.01* 30,469 SES 2 1.29 (1.24-1.34) <.01* 18,956 SES 3 1.42 (1.34-1.50) <.01* 6,789 SES 4 1.50 (1.45-1.55) <.01* 34,923 SES (invitees with BC) SES 1 reference 0.08 1,080 SES 2 1.06 (0.89-1.27) 0.55 789 SES 3 1.18 (0.91-1.54) 0.21 277 SES 4 1.22 (1.04-1.42) 0.01* 1,529 Stage CIS reference <.01* 517 Stage 1 0.95 (0.78-1.16) 0.61 1,469 Stage 2 0.49 (0.40-0.61) <.01* 1,116 Stage 3 0.32 (0.24-0.42) <.01* 316 Stage 4 0.15 (0.10-0.24) <.01* 156 SES x Stage SES 4 x CIS reference <.01* 217 SES 4 x Stage 1 0.78 (0.57-1.09) 0.15 620 SES 4 x Stage 2 0.46 (0.33-0.64) <.01* 465 SES 4 x Stage 3 0.35 (0.22-0.56) <.01* 125 SES 4 x Stage 4 0.17 (0.09-0.32) <.01* 62 SES 3 x CIS 0.59 (0.30-1.18) 0.13 38 SES 3 x Stage 1 0.68 (0.43-1.08) 0.10 119 SES 3 x Stage 2 0.54 (0.33-0.88) 0.01* 93 SES 3 x Stage 3 0.20 (0.07-0.59) 0.01* 18 SES 3 x Stage 4 0.00 (0.00-0.00) 1.00 1 SES 2 x CIS 0.82 (0.51-1.32) 0.41 107 SES 2 x Stage 1 0.84 (0.59-1.21) 0.35 319 SES 2 x Stage 2 0.32 (0.22-0.47) <.01* 229 SES 2 x Stage 3 0.26 (0.15-0.44) <.01* 82 SES 2 x Stage 4 0.13 (0.05-0.34) <.01* 30 3
RkJQdWJsaXNoZXIy MTk4NDMw